Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.

For more information on how to use this blog
click here, the HCV drug pipeline click here, and for more information on HCV clinical trials click here

Be sure to check out our other blogs: The HBV Advocate Blog and Hepatitis & Tattoos.

Alan Franciscus
Editor-in-Chief
HCV Advocate
HBV Advocate

Friday, September 9, 2011

Cancer, rheumatism drugs tied to hep B deaths

A number of people who had recovered from past hepatitis B infections died due to a sudden and acute reactivation of the virus in their bodies after taking newly introduced drugs to treat such conditions as rheumatism and blood cancer, according to health ministry research.

The people who died from fulminant hepatitis had weakened immune systems as a result of using new drugs to treat other conditions, according to a research team at the ministry and other sources.

Read more....

No comments:

Post a Comment